TERUMO CORPORATION (4543) Stock Price

Terumo operates three business segments: the Cardiovascular Company, the Medical Care Solutions Company, and the Blood & Cell Technology Company. These segments align with the segment information presented in Terumo's consolidated financial statements.

The Cardiovascular Company provides medical devices and services related to the heart and blood vessels. Specifically, it develops products such as cardiac catheters and stents to support the treatment of heart disease.

The Medical Care Solutions Company offers products and services that support care delivery in clinical settings. For example, it provides solutions for efficient patient treatment through medical devices such as syringes and infusion pumps.

The Blood & Cell Technology Company develops products utilizing blood and cell-related technologies. It supplies blood bags and cell culture equipment, addressing needs in the fields of transfusion and cell therapy.

Terumo is guided by a corporate mission to contribute to society through healthcare, with all employees conducting business activities based on this mission. Terumo's growth strategy "GS26" aims to respond to changes in healthcare and transition from devices to solutions. This strategy is centered on three business segments: Cardiovascular, Medical Care Solutions, and Blood & Cell Technology.

"GS26" focuses on three "D"s. First, Delivery leverages the Cardiovascular Company's catheter technology expertise to drive development of new solutions. Second, Digital utilizes digital technology to improve efficiency and optimization in healthcare. Third, Deviceuticals pursues the convergence of medical devices and pharmaceuticals to deliver high-value products.

The Cardiovascular Company aims to expand its treatment business through new product launches and the adoption of radial procedures. It also pursues global production optimization and operational efficiency through digital transformation to improve profitability. The Medical Care Solutions Company provides patient-centered solutions and contributes to improved quality of care.

The Blood & Cell Technology Company leverages the potential of blood and cells to enhance therapeutic outcomes. It pursues global growth through regional expansion and operational excellence. Through these strategies, Terumo aims to co-create sustainable healthcare systems and enhance corporate value.